Assessment of Potential Thrombogenicity of Coagulation Factor IX Concentrates in an in Vitro Model of Human Thrombogenesis - Evidence from experimental studies using a perfusion technique

By Galan A.M.   Reverter J.C.   Bozzo J.   Hernandez M.R.   Escolar G.   Aznar-Salatti J.  

Thrombosis Research, Vol. 96, Iss. 5, 1999-12 ,pp. : 383-389

Elsevier

Access to resources Recommend Favorite

EFFECT OF MULTIMERIZATION OF HUMAN AND RECOMBINANT VON WILLEBRAND FACTOR ON PLATELET AGGREGATION, BINDING TO COLLAGEN AND BINDING OF COAGULATION FACTOR VIII

By Fischer B.E.   Kramer G.   Mitterer A.   Grillberger L.   Reiter M.   Mundt W.   Dorner F.   Eibl J.  

Thrombosis Research, Vol. 84, Iss. 1, 1996-10 ,pp. : 55-66

Elsevier

Access to resources Recommend Favorite

Recombinant Human Insulin-Like Growth Factor-1: A New Cardiovascular Disease Treatment Option?

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 6, Iss. 4, 2008-01 ,pp. : 258-271

Bentham Science Publishers

Access to resources Recommend Favorite

Cloning and Recombinant Expression of Mouse Coagulation Factor X - structural aspects of thrombin, factor Xa, factor IXa and protein C

By Heidtmann H.-H.   Kontermann R.E.  

Thrombosis Research, Vol. 92, Iss. 1, 1998-10 ,pp. : 33-41

Elsevier

Access to resources Recommend Favorite

TISSUE FACTOR PATHWAY INHIBITOR IN COMPLEX WITH LOW DENSITY LIPOPROTEIN ISOLATED FROM HUMAN PLASMA DOES NOT POSSESS ANTICOAGULANT FUNCTION IN TISSUE FACTOR-INDUCED COAGULATION IN VITRO

By Hansen J.-B.   Huseby K.R.   Huseby N.-E.   Ezban M.   Nordoy A.  

Thrombosis Research, Vol. 85, Iss. 5, 1997-03 ,pp. : 413-425

Elsevier

Access to resources Recommend Favorite